Onconetics Pharmaceuticals, Inc.
San Francisco · Founded 2016
About Onconetics Pharmaceuticals, Inc.
Onconetics Pharmaceuticals, Inc. is an early-stage pharmaceutical startup based in San Francisco, California. Onconetics engages in research and drug development for the emerging and highly sought-after field of personalized medicine in order to develop treatments for cancer and other genetic disorders. It combines well-established gene therapy techniques with pioneering research to create novel therapeutic outcomes that seek to change the highly invasive, costly, and uncertain nature of traditional therapies. Onconetics aims to create simpler, more versatile personalized therapies for cancer and genetic disorders that pose little or no risk to the patient and their quality of life, while pushing the frontiers of our understanding of the microscopic world.
Company Facts
- Founded: 2016
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Oct 2017)
- Website: onconetics.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/onconetics-pharmaceuticals-inc-8328543 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.